518 related articles for article (PubMed ID: 22226665)
21. Id-1 induces cell invasiveness in immortalized epithelial cells by regulating cadherin switching and Rho GTPases.
Cheung PY; Yip YL; Tsao SW; Ching YP; Cheung AL
J Cell Biochem; 2011 Jan; 112(1):157-68. PubMed ID: 21053361
[TBL] [Abstract][Full Text] [Related]
22. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
23. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
24. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
25. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
Baumgart E; Cohen MS; Silva Neto B; Jacobs MA; Wotkowicz C; Rieger-Christ KM; Biolo A; Zeheb R; Loda M; Libertino JA; Summerhayes IC
Clin Cancer Res; 2007 Mar; 13(6):1685-94. PubMed ID: 17363521
[TBL] [Abstract][Full Text] [Related]
26. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
Wu CL; Ho JY; Chou SC; Yu DS
Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
[TBL] [Abstract][Full Text] [Related]
27. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition.
Jing Y; Cui D; Guo W; Jiang J; Jiang B; Lu Y; Zhao W; Wang X; Jiang Q; Han B; Xia S
Cancer Lett; 2014 Jun; 348(1-2):135-45. PubMed ID: 24662746
[TBL] [Abstract][Full Text] [Related]
28. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
[TBL] [Abstract][Full Text] [Related]
29. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
[TBL] [Abstract][Full Text] [Related]
30. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
[TBL] [Abstract][Full Text] [Related]
32. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
[TBL] [Abstract][Full Text] [Related]
33. Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer.
Olivo M; Lucky SS; Kent Mancer JF; Lau WK
Urol Oncol; 2012 Sep; 30(5):624-34. PubMed ID: 20933443
[TBL] [Abstract][Full Text] [Related]
34. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
35. Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and β-catenin and enhances invasion in nasopharyngeal carcinoma cells.
Yip WK; Seow HF
Cancer Lett; 2012 May; 318(2):162-72. PubMed ID: 22182447
[TBL] [Abstract][Full Text] [Related]
36. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies.
Bryan RT; Atherfold PA; Yeo Y; Jones LJ; Harrison RF; Wallace DM; Jankowski JA
J Pathol; 2008 Jun; 215(2):184-94. PubMed ID: 18393367
[TBL] [Abstract][Full Text] [Related]
37. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
[TBL] [Abstract][Full Text] [Related]
38. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
